Join

Compare · BBC vs HCXY

BBC vs HCXY

Side-by-side comparison of Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Hercules Capital, Inc. (HCXY): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both BBC and HCXY operate in n/a (n/a), so they compete in similar markets.
  • HCXY carries a market cap of $4.43B.
  • HCXY has hit the wire 4 times in the past 4 weeks while BBC has been quiet.
MetricBBCHCXY
Company
Virtus LifeSci Biotech Clinical Trials ETF
Hercules Capital, Inc.
Price
-
-
Market cap
-
$4.43B
1M return
-20.92%
-
1Y return
+27.90%
-
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NASDAQ
NYSE
IPO
n/a
2018
News (4w)
0
4
Recent ratings
0
0
BBC

Virtus LifeSci Biotech Clinical Trials ETF

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

Latest BBC

Latest HCXY